Synchrony's CareCredit and Daybreak Partner to Provide Better Sleep for Americans
Synchrony (NYSE: SYF) and Daybreak have partnered to offer flexible financing for sleep testing kits and sleep apnea devices through CareCredit health and wellness credit card. The three-year partnership, running through March 31, 2027, aims to make sleep health solutions more accessible to the estimated 50-70 million Americans living with sleep disorders. Since July 2024, Daybreak customers can apply for CareCredit's promotional financing to purchase at-home sleep test kits or proprietary sleep apnea devices. The partnership addresses the financial barriers to sleep health care, particularly for those without insurance coverage for in-lab sleep studies.
Synchrony (NYSE: SYF) e Daybreak hanno stretto una partnership per offrire finanziamenti flessibili per kit di test del sonno e dispositivi per l'apnea notturna tramite la carta di credito per la salute e il benessere CareCredit. Questa partnership triennale, che si concluderà il 31 marzo 2027, ha l'obiettivo di rendere le soluzioni per la salute del sonno più accessibili ai circa 50-70 milioni di americani che vivono con disturbi del sonno. A partire da luglio 2024, i clienti di Daybreak potranno richiedere il finanziamento promozionale di CareCredit per l'acquisto di kit di test del sonno per uso domestico o dispositivi proprietari per l'apnea notturna. La partnership affronta le barriere finanziarie all'assistenza sanitaria per il sonno, in particolare per coloro che non hanno copertura assicurativa per gli studi del sonno in laboratorio.
Synchrony (NYSE: SYF) y Daybreak se han asociado para ofrecer financiamiento flexible para kits de pruebas de sueño y dispositivos para la apnea del sueño a través de la tarjeta de crédito para salud y bienestar CareCredit. La asociación de tres años, que se extenderá hasta el 31 de marzo de 2027, tiene como objetivo hacer que las soluciones de salud del sueño sean más accesibles para los aproximadamente 50-70 millones de estadounidenses que viven con trastornos del sueño. A partir de julio de 2024, los clientes de Daybreak podrán solicitar financiamiento promocional de CareCredit para comprar kits de pruebas de sueño a domicilio o dispositivos de apnea del sueño patentados. La asociación aborda las barreras financieras para el cuidado de la salud del sueño, especialmente para aquellos que no tienen cobertura de seguro para estudios del sueño en laboratorio.
Synchrony (NYSE: SYF)와 Daybreak가 CareCredit 건강 및 웰니스 신용카드를 통해 수면 테스트 키트와 수면 무호흡 장치에 대한 유연한 자금을 제공하기 위해 파트너십을 체결했습니다. 이 3년 파트너십은 2027년 3월 31일까지 진행되며, 수면 장애를 앓고 있는 약 5천만~7천만 명의 미국인들이 수면 건강 솔루션을 더 쉽게 접근할 수 있도록 하는 것을 목표로 하고 있습니다. 2024년 7월부터 Daybreak 고객은 자택용 수면 테스트 키트나 독점 수면 무호흡 장치를 구매하기 위해 CareCredit의 프로모션 자금을 신청할 수 있습니다. 이 파트너십은 실험실 수면 연구에 대한 보험 적용이 없는 사람들에게 특히 수면 건강 관리에 대한 재정적 장벽을 해결합니다.
Synchrony (NYSE: SYF) et Daybreak ont établi un partenariat pour offrir des financements flexibles pour des kits de test de sommeil et des dispositifs pour l'apnée du sommeil via la carte de crédit santé et bien-être CareCredit. Ce partenariat de trois ans, qui se poursuivra jusqu'au 31 mars 2027, vise à rendre les solutions de santé du sommeil plus accessibles aux 50 à 70 millions d'Américains vivant avec des troubles du sommeil. À partir de juillet 2024, les clients de Daybreak pourront demander le financement promotionnel de CareCredit pour acheter des kits de test de sommeil à domicile ou des dispositifs propriétaires pour l'apnée du sommeil. Ce partenariat aborde les barrières financières à l'accès aux soins de santé du sommeil, en particulier pour ceux qui n'ont pas de couverture d'assurance pour les études de sommeil en laboratoire.
Synchrony (NYSE: SYF) und Daybreak haben eine Partnerschaft geschlossen, um flexible Finanzierungsangebote für Schlaftestkits und Geräte gegen Schlafapnoe über die CareCredit-Gesundheits- und Wellness-Kreditkarte anzubieten. Die dreijährige Partnerschaft, die bis zum 31. März 2027 läuft, zielt darauf ab, Schlafgesundheitslösungen für die geschätzten 50-70 Millionen Amerikaner, die an Schlafstörungen leiden, zugänglicher zu machen. Ab Juli 2024 können die Kunden von Daybreak die promotionale Finanzierung von CareCredit beantragen, um Schlaftestkits für zu Hause oder proprietäre Geräte gegen Schlafapnoe zu erwerben. Die Partnerschaft adressiert die finanziellen Barrieren im Bereich der Schlafgesundheitsversorgung, insbesondere für jene ohne Versicherungsschutz für laborgestützte Schlafstudien.
- Partnership expands Synchrony's market presence in the growing sleep health sector
- Three-year agreement provides steady revenue stream through March 2027
- Targets large market opportunity with 50-70 million Americans having sleep disorders
- Expands CareCredit's utility and customer base
- None.
Insights
This partnership represents a strategic expansion of Synchrony's CareCredit platform into the growing sleep health market, estimated to be worth
The deal leverages SYF's existing healthcare financing infrastructure while expanding into the direct-to-consumer sleep diagnostics segment. With
The financing terms weren't disclosed, but similar CareCredit partnerships typically generate
CareCredit health and wellness credit card now accepted as a payment option for Daybreak's sleep testing-kits and sleep apnea device
"The evidence is increasingly pointing to quality sleep being a pillar of good health," said Claude Royster, Vice President and General Manager of Wellness at Synchrony. "Unfortunately, achieving consistent, restful sleep may not be possible for people who are unknowingly living with a sleep disorder or condition. That is where Daybreak's at-home sleep solutions can help people get clarity on their current sleep health and lay the foundation that sets them up for better care and sleep."
Sleep hygiene has a ripple effect on our health with poor sleep linked to memory issues, moodiness, a diminished immune system and weight-gain, among other side-effects. However, pursuing in-lab sleep studies may present a significant healthcare expense to consumers with out-of-pocket costs for these assessments. Those costs can make it particularly difficult for people who do not have insurance to seek out important diagnostic services. Daybreak's products are available to consumers in the comfort of their own homes and their FDA cleared, custom-fit oral solution, "Daybreak Sleep System," has been shown to successfully reduce snoring and hypopnea events even on the first night of use.
"Working with Daybreak is an extension of our continued commitment to help consumers pursue their health and wellness goals," said Erin Gadhavi, Senior Vice President and General Manager of Wellness at Synchrony. "Getting to collaborate like this is one way we try to expand the utility of our card for our customers, and we look forward to seeing how CareCredit may empower more people to seek care for their sleep issues."
Since July 2024, Daybreak customers have been able to apply for and use CareCredit's promotional financing offerings to purchase an at-home sleep test kit or a proprietary sleep apnea device to take control of their sleep health. This partnership will span three-years through March 31, 2027, and is the latest sleep health offering backed by CareCredit, which provides financing for a range of brands from Sleep Number to Daybreak.
"We understand the financial hurdles that consumers may face when it comes to improving their sleep health, which is why we're eager to see the impact this partnership may have on those that have been delaying care due to costs," said Van Morgan, Daybreak CEO and Co-founder. "Through this united effort with CareCredit, we aim to help consumers confidently seek out the sleep solutions they want and need so they can achieve a healthier tomorrow through better sleep today."
The Daybreak partnership is the latest for Synchrony as part of its ongoing commitment to making health and wellness products or services more accessible for consumers. Synchrony's CareCredit card is an efficient way for people to pay for health and wellness products online or at select retail locations, in ways that fit their budgets. For consumers interested in Daybreak's solutions, ask a provider or visit the Daybreak website for more information.
About Daybreak
Daybreak is a leading provider of fully at-home sleep testing kits and custom-fit sleep apnea devices, especially for those looking for a Continuous Positive Airway Pressure (CPAP) alternative. Founded by a team of leading sleep health physicians and dentists, we're revolutionizing the way sleep apnea is diagnosed and treated. Our mission is to reshape the health trajectories of millions affected by untreated obstructive sleep apnea by reimagining the sleep apnea journey, allowing doctor-directed care to unfold completely at-home — from diagnosis to treatment. Our devoted team of sleep medicine experts have developed an evidence-based and custom-tailored process. Every night's sleep has the potential to propel us toward a healthier tomorrow and we believe that better days start at Daybreak. For more information, visit www.thedaybreak.com.
About Synchrony
Synchrony (NYSE: SYF) is a premier consumer financial services company delivering one of the industry's most complete digitally-enabled product suites. Our experience, expertise and scale encompass a broad spectrum of industries including digital, health and wellness, retail, telecommunications, home, auto, outdoor, pet and more. We have an established and diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers, which we refer to as our "partners." We connect our partners and consumers through our dynamic financial ecosystem and provide them with a diverse set of financing solutions and innovative digital capabilities to address their specific needs and deliver seamless, omnichannel experiences. We offer the right financing products to the right customers in their channel of choice. For more information, visit www.synchrony.com.
Media Relations:
Michelle Blaya Romero
Synchrony
Michelle.Romero@SYF.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/synchronys-carecredit-and-daybreak-partner-to-provide-better-sleep-for-americans-302320236.html
SOURCE Synchrony Financial
FAQ
When did Synchrony (SYF) partner with Daybreak for sleep health financing?
How long will Synchrony's (SYF) partnership with Daybreak last?
What products can be financed through Synchrony's (SYF) CareCredit at Daybreak?
What is the market size for Synchrony's (SYF) sleep health financing partnership?
